ARCHIVES

U.S., Canada Begin ExCel Trial To Evaluate Aromasin For Breast Cancer Prevention

This article is from The Cancer Letter archive.

Vol. 28 No. 4 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Remains Exception To NIH Authority Over Scientific Counselors

January 27, 1995

California Land Control Grant, Need Administrator

April 21, 1978

DCPC Board Approves Concepts Of Six New RFAs Totaling $9.3 Million A Year

May 11, 1984

CCOP Review Committees Listed

February 6, 1987

Obama Lifts Ban on Federal Funding for Embryonic Stem Cell Research, Signs Memo on Scientific Integrity

March 13, 2009

Oral Capecitabine Equal To 5FU-Leucovorin In Adjuvant Stage III Colon Cancer Treatment

June 25, 2004